HNO signaling mechanisms

Antioxidants and Redox Signaling

Volumn 14, Issue 9, 2011, Pages 1649-1657

  Fukuto, Jon M ^a   Carrington, Samantha J ^a  

^a SONOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CARDIOVASCULAR AGENT; CYANAMIDE; ELECTROPHILE; METALLOPROTEIN; NITROSYL HYDRIDE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ALCOHOLISM; HEART FAILURE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW;

ANIMALS; HUMANS; METALLOPROTEINS; NITROGEN OXIDES; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS;

EID: 79953786206     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3855     Document Type: Review

References (72)

1. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favarolo JL, Triggle CR, and Kemp-Harper BK. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpo-larizing factor in resistance arteries. Br J Pharmacol 157: 540-550, 2009.
2. Bai P, Bakondi E, Szabo E, Gergely P, Szabo C, and Virag, L. Partial protection by poly(ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes. Free Radic Biol Med 31: 1616-1623, 2001. (Pubitemid 34024984)
3. Bari SE, Marti M, Amorebieta VT, Estrin DA, and Doctor-ovich F. Fast nitroxyl trapping by ferric porphyrins. J Am Chem Soc 125: 15272-15273, 2003. (Pubitemid 37532155)
4. Bartberger MD, Fukuto JM, and Houk KN. On the acidity and reactivity of HNO in aqueous solution and biological systems. Proc Natl Acad Sci USA 98: 2194-2198, 2001. (Pubitemid 32209458)
5. Bartberger MD, Liu W, Ford E, Miranda KM, Switzer C, Fukuto JM, Farmer PJ, Wink DA, and Houk KN. The reduction potential of nitric oxide (NO) and its importance to NO biochemistry. Proc Natl Acad Sci USA 99: 10958-10963, 2002. (Pubitemid 34920861)
6. Bermejo E, Saenz DA, Alberto, F, Rosenstein RE, Bari SE, and Lazzzari MA. Effect of nitroxyl on human platelet function. Thromb Haemostasis 94: 578-584, 2005. (Pubitemid 41300855)
7. Bonner FT and Hughes MN. The aqueous solution chemistry of nitrogen in low positive oxidation states. Comments Inorg Chem 7: 215-234, 1988.
8. Buyukafsar K, Nelli S, and Martin W. Formation of nitric oxide from nitroxyl anion: role of quinones and ferricyto-chrome c. Br J Pharmacol 132: 165-172, 2001. (Pubitemid 32128446)
9. 2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37: 87-96, 2005. (Pubitemid 39497152)
10. Claiborne A, Miller H, Parsonage D, and Ross RP. Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB J 7: 1483-1490, 1993. (Pubitemid 24003268)
11. Colton CA, Gbadegesin M, Wink DA, Miranda KM, Espey MG, and Vicini S. Nitroxyl anion regulation of the NMDA receptor. J Neurochem 78: 1126-1134, 2001. (Pubitemid 32823161)
12. Craven PA and DeRubertis FR. Effects of thiol inhibitors on hepatic guanylate cylase activity. Biochim Biophys Acta 524: 231-244, 1978.
13. Craven PA and DeRubertis FR. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide. Biochim Biophys Acta 745: 310-321, 1983.
14. Dai T, Tian Y, Tochetti G, Kator T, Murphy AM, Kass DA, Paolocci N, and Gao WD. Nitroxyl increases force development in rat cardiac muscle. J Physiol 580: 951-960, 2007. (Pubitemid 46909044)
15. DeMaster EG, Shirota FN, and Nagasawa HT. Catalase mediated conversion of cyanamide to an inhibitor of aldehyde dehydrogenase. Alcohol 2: 117-121, 1985. (Pubitemid 15119122)
16. DeMaster EG, Redfern B, and Nagasawa HT. Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide. Biochem Pharmacol 55: 2007-2015, 1998. (Pubitemid 28477471)
17. DeMaster EG, Redfern B, Quast BJ, Dahlseid T, and Nagasawa HT. Mechanism for the inhibition of aldehyde dehydrogenase by nitric oxide. Alcohol 14: 181-189, 1997. (Pubitemid 27147337)
18. Dierks EA and Burstyn JN. Nitric oxide (NO$), the only nitrogen monoxide redox form capable of activating soluble guanylate cyclase. Biochem Pharmacol 51: 1593-1600, 1996.
19. Dixon RN. The heats of formation of HNO and DNO. J Chem Phys 104: 6905-6906, 1996.
20. Doyle MP, Mahapatro SN, Broene RD, and Guy JK. Oxidation and reduction of hemoproteins by trioxodinitrate(II): the role of nitrosyl hydride and nitrite. J Am Chem Soc 110: 593-599, 1988.
21. Farmer PJ and Sulc F. Coordination chemistry of the HNO ligand with hemes and synthetic porphyrin complexes. J Inorg Biochem 99: 166-184, 2005. (Pubitemid 39646482)
22. Feelisch M. Nitroxyl gets to the heart of the matter. Proc Natl Acad Sci USA 100: 4978-4980, 2003. (Pubitemid 36542643)
23. Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, and Toscano JP. Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47: 13150-13152, 2008.
24. Fukuto JM, Chiang K, Hszieh R, Wong P, and Chaudhuri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther 263: 546-551, 1992.
25. Fukuto JM, Bartberger MD, Dutton AS, Paolocci N, Wink DA, and Houk KN. The physiological chemistry and biologicalactivity of nitroxyl (HNO): the neglected, misunderstood and enigmatic nitrogen oxide. Chem Res Toxicol 18: 790-801, 2005. (Pubitemid 40705445)
26. Fukuto JM, Bianco CL, and Chavez TA. Nitroxyl (HNO) Signaling. Free Radic Biol Med 47: 1318-1324, 2009.
27. Gao WD, Liu Y, and Marban E. Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Circulation 94: 2597-2604, 1996.
28. Gratzel M, Taniguchi S, and Henglein A. A pulse radiolytic study of short-lived byproducts on nitric oxide reduction in aqueous solution. Ber Bunsenges Phys Chem 74: 1003-1010, 1970.
29. Hammond AH and Fry JR. Effect of cyanamide on toxicity and glutathione depletion in rat hepatocyte cultures: differences between two dichloropropanol isomers. Chem Biol Interact 122: 107-115, 1999. (Pubitemid 29414814)
30. Hildago C, Donoso P, and Carrasco MA. The ryanodine receptors Ca2 + release channels: cellular redox sensors? IUBMB Life 57: 315-322, 2005. (Pubitemid 40904260)
31. Hoffmann R, Gleiter R, and Mallory FB. Non-least motion potential surfaces. Dimerization of methylenes and nitroso compounds. J Am Chem Soc 92: 1460-1466, 1970.
32. Hoffman MD, Walsh GM, Rogalski JC, and Kast J. Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol Cell Proteomics 8: 887-903, 2009.
33. Irvine JC, Favaloro JL, and Kemp-Harper BK. NO-activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension 41: 1301-1307, 2003. (Pubitemid 36706081)
34. Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, and Kemp-Harper BK. Nitroxyl (HNO): the Cinderella of the nitric oxide story. TIPS 29: 601-608, 2008.
35. Jackson MI, Han TH, Dutton A, Ford E, Miranda KM, Houk KN, Wink DA, and Fukuto JM. Kinetic feasibility of nitroxyl (HNO) reduction by physiological reductants and biological implications. Free Radic Biol Med 47: 1130-1139, 2009.
36. Karim CB, Stamm JD, Karim J, Jones LR, and Thomas DD. Cysteine reactivity and oligomeric structures of phospho-lamban and its mutants. Biochemistry 37: 12074-12081, 1998. (Pubitemid 28411291)
37. -. Neuron 24: 461-469, 1999. (Pubitemid 29508419)
38. 2+-cylcing. Front Biosci E2: 614-626, 2010.
39. Koppenol WH, Moreno JJ, Pryor WA, Ishiropoulos H, and Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5: 834-842, 1992. (Pubitemid 23004874)
40. 2 analogue: long-lived HNO adducts of ferrous globins. Biochemistry 48: 5018-5025, 2009.
41. Lancel S, Zhang J, Evangelista A, Trucillo MP, Tong XY, Siwik DA, Cohen RA, and Colucci WS. Nitroxyl activates SERCA in cardiac myocytes via glutathionylation of cysteine 674. Circ Res 104: 720-723, 2009.
42. Lin R and Farmer PJ. The HNO adduct of myoglobin: synthesis and Characterization. J Am Chem Soc 122: 2393-2394, 2000. (Pubitemid 30164661)
43. Lopez BE, Rodriguez CE, Pribadi M, Cook N, Shinyashiki M, and Fukuto JM. Selective inhibition of yeast glycolysis by nitroxyl (HNO): implications to HNO pharmacology/ physiology. Arch Biochem Biophys 442: 140-148, 2005. (Pubitemid 41331000)
44. Ma XL, Gao F, Liu GL, Lopez BL, Christopher TA, Fukuto JM, Wink DA, and Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci USA 96: 14617-14622, 1999. (Pubitemid 30000699)
45. Miller TW, Cherney ME, Lee AJ, Francoleon N, Farmer PJ, King SB, Hobbs AJ, Miranda K, Burstyn JN, and Fukuto JM. The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols. J Biol Chem 284: 21788-21796, 2009.
46. Miranda KM. The chemistry of nitroxyl (HNO) and implications in biology. Coord Chem Rev 249: 433-455, 2005. (Pubitemid 40093751)
47. Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, Espey MG, Kass DA, Fukuto JM, and Wink DA. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci USA 100: 9197-9201, 2003.
48. Miranda KM, Nagasawa HT, and Toscano JP. Donors of HNO. Curr Top Med Chem 5: 649-664, 2005. (Pubitemid 41179725)
49. Moore EG and Gibson QH. Cooperativity in the dissociation of nitric oxide from hemoglobin. J Biol Chem 251: 2788-2794, 1976.
50. Nagasawa HT, Lee MJC, Kwon CH, Shirota FN, and De-Master EG. An N-hydroxylated derivative of cyanamide that inhibits yeast aldehyde dehydrogenase. Alcohol 9: 349-353, 1992.
51. Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, and Paolooci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34: 33-43, 2003. (Pubitemid 36043884)
52. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, and Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci USA 98: 10463-10468, 2001. (Pubitemid 32803042)
53. - in failing hearts: Independence from b-adrenergic signaling. Proc Natl Acad Sci USA 100: 5537-5542, 2003. (Pubitemid 36542740)
54. Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, and Fukuto JM. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the janus face of NO. Pharmacol Ther 113: 442-458, 2007.
55. Reisz JA, Klorig EB, Wright MW, and King SB. Reductive phophine-mediated ligation of nitroxyl (HNO). Org Lett 11: 2719-2721, 2009.
56. Schmalhausen EV, Muronetz VI, and Nagradova NK. Rabbit muscle GAPDH: non-phosphorylating dehydrogenase activity induced by hydrogen peroxide. FEBS Lett 414: 247-252, 1997. (Pubitemid 27389372)
57. Shafirovich V and Lymar SV. Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide. Proc Natl Acad Sci USA 99: 7340-7345, 2002. (Pubitemid 34575345)
58. Shafirovich V and Lymar SV. Spin-forbidden deprotonation of aqueous nitroxyl (HNO). J Am Chem Soc 125: 6547-6552, 2003. (Pubitemid 36605421)
59. Shen B and English AM. Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines. Biochemistry 44: 14030-14044, 2005. (Pubitemid 41507483)
60. Shiva SCJ, Ramachandran A, Ceaser EK, Hillson T, Brookes PS, Patel RP, and Darley-Usmar VM. Mechanisms of the interaction of nitroxyl with mitochondria. Biochem J 379: 359-366, 2004. (Pubitemid 38570109)
61. Shoeman DW, Shirota FN, DeMaster EG, and Nagasawa HT. Reaction of nitroxyl, an aldehyde dehydrogenase inhibitor, with N-acetyl cysteine. Alcohol 20: 55-59, 2000. (Pubitemid 30058349)
62. Stone JR, Sands RH, Dunham WR, and Marletta MA. Spectral and ligand-binding properties of an unusual he-moprotein, the ferric form of soluble guanylate cyclase. Biochemistry 35: 3258-3262, 1996. (Pubitemid 26082253)
63. 1H NMR structure of the heme pocket of HNO-myoglobin. J Biol Inorg Chem 8: 348-352, 2003. (Pubitemid 36232272)
64. Sulc F, Immoos CE, Pervitsky D, and Farmer PJ. Efficient trapping of HNO by deoxymyoglobin. J Am Chem Soc 126: 1096-1101, 2004. (Pubitemid 38140740)
65. 2+ release in cardiac myocytes. Free Radic Biol Med 24: 318-325, 1998. (Pubitemid 28008810)
66. 2+ cycling. Circ Res 100: 96-104, 2007. (Pubitemid 46066777)
67. Vaananen AJ, Kankuri E, and Rauhala P. Nitric oxide-related species-induced protein oxidation: reversible, irreversible and protective effects on enzyme function of papain. Free Radic Biol Med 38: 1102-1111, 2005. (Pubitemid 40386556)
68. Vaananen AJ, Salmenpera P, Hukkanen M, Rauhala P, and Kankuri E. Cathepsin B is a differentiation-resistant target for nitroxyl (HNO) in THP-1 monocyte/macrophages. Free Radic Biol Med 41: 120-131, 2006. (Pubitemid 43884781)
69. Vaananen A, Salmenpera P, Hukkanen M, Miranda KM, Harjula A, Rauhala P, and Kankuri E. Persistent susceptibility of cathepsin B to irreversible inhibition by nitroxyl (HNO) in the presence of endogenous nitric oxide. Free Radic Biol Med 45: 749-755, 2008.
70. Winterbourne CC and Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 27: 322-329, 1999.
71. Wong PSY, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, and Nagasawa HT. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry 37: 5362-5371, 1998. (Pubitemid 28241917)
72. Zeller A, Wenzl MV, Beretta M, Stesse H, Russwurm M, Koesling D, Schmidt K, and Mayer B. Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt. Mol Pharm 76: 1115-1122, 2009.